Following a personal tragedy, vice president Joe Biden has sworn to dedicate his last year in office to help boost cancer research.
Following a personal tragedy—the loss of his oldest son to brain cancer late last year—vice president Joe Biden has sworn to dedicate his last year in office to help boost cancer research, “Because I know there are Democrats and Republicans on the Hill who share our passion, our passion to silence this deadly disease,” he said in a press briefing last year.
Biden’s staff, meanwhile, have set the wheels in motion, meeting with a group of researchers from the American Association of Cancer Research (AACR) last week to focus on smaller initiatives that stand a chance of getting done within this short time frame of a year. During an 80-minute meeting with AACR scientists, Biden’s top policy staffers said they were interested in things beyond discovery—which takes years of investment—but something else that can be more impactful, according to AACR president Jose Baselga, MD, who spoke with STAT. “They are on a time crunch. They know that there is one year left of his administration. They had a sense of urgency,” Baselga said.
Baselga said in his interview that an issue of interest was to develop a national open-access data-sharing initiative for scientists. This would be similar to what the American Society of Clinical Oncology is trying with its CancerLinQ initiative—a health information technology platform that is being developed to aggregate and analyze real-world cancer data that can provide real-time performance feedback to providers in comparison with their peers; provide real-time clinical decision support; and help providers uncover patterns in patient characteristics, treatments, and outcomes, to improve care.
The scientists also drew the aides’ attention to the importance of next generation gene sequencing in personalized medicine.
Also present at the meeting was George Demetri, MD, of the Dana-Farber Cancer Institute. He told STAT that Biden’s staff discussed ways to break down silos, and the data-sharing initiative could be an important step in the direction.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
November 13th 2024Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Read More